"Methysergide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
An ergot derivative that is a congener of LYSERGIC ACID DIETHYLAMIDE. It antagonizes the effects of serotonin in blood vessels and gastrointestinal smooth muscle, but has few of the properties of other ergot alkaloids. Methysergide is used prophylactically in migraine and other vascular headaches and to antagonize serotonin in the carcinoid syndrome.
Descriptor ID |
D008784
|
MeSH Number(s) |
D03.132.327.287.689 D03.633.400.439.689
|
Concept/Terms |
Methysergide- Methysergide
- Dimethylergometrin
- Methylmethylergonovine
Sansert- Sansert
- Deseril
- Désernil-Sandoz
- Désernil Sandoz
- Desril
|
Below are MeSH descriptors whose meaning is more general than "Methysergide".
Below are MeSH descriptors whose meaning is more specific than "Methysergide".
This graph shows the total number of publications written about "Methysergide" by people in this website by year, and whether "Methysergide" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1998 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Methysergide" by people in Profiles.
-
Pharmacological therapy in progressive supranuclear palsy. Arch Neurol. 1998 Aug; 55(8):1099-102.
-
Drug-induced myoclonus. Adv Neurol. 1986; 43:251-64.
-
Levodopa-induced myoclonus. Arch Neurol. 1975 May; 32(5):330-4.
-
5-Hydroxytryptophan-induced myoclonus in guinea pigs and the possible role of serotonin in infantile myoclonus. Neurology. 1973 Nov; 23(11):1234-40.